Related Experiment Video
Updated: Jun 20, 2026

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Published on: March 3, 2023
Antibiotics for emerging pathogens
Michael A Fischbach1, Christopher T Walsh
1Department of Molecular Biology and Center for Computational and Integrative Biology, Massachusetts General Hospital, Boston, MA 02114, USA. fischbach@fischbachgroup.org
Abstract:
Antibiotic-resistant strains of pathogenic bacteria are increasingly prevalent in hospitals and the community. New antibiotics are needed to combat these bacterial pathogens, but progress in developing them has been slow. Historically, most antibiotics have come from a small set of molecular scaffolds whose functional lifetimes have been extended by generations of synthetic tailoring. The emergence of multidrug resistance among the latest generation of pathogens suggests that the discovery of new scaffolds should be a priority. Promising approaches to scaffold discovery are emerging; they include mining underexplored microbial niches for natural products, designing screens that avoid rediscovering old scaffolds, and repurposing libraries of synthetic molecules for use as antibiotics.
Insights
New strategies are urgently needed to discover novel antibiotic scaffolds to combat rising drug-resistant bacteria. Exploring new microbial sources and repurposing synthetic molecules offers promising avenues for antibiotic development.
Area of Science:
- Microbiology
- Medicinal Chemistry
- Drug Discovery
Background:
- Increasing prevalence of antibiotic-resistant pathogenic bacteria in healthcare settings and communities.
- Slow progress in developing new antibiotics due to reliance on established molecular scaffolds.
- Emergence of multidrug resistance necessitates the discovery of novel antibiotic scaffolds.
Purpose of the Study:
- To highlight the urgent need for new antibiotic scaffolds.
- To discuss promising approaches for discovering novel antibiotic scaffolds.
- To address the challenge of multidrug resistance in bacterial pathogens.
Main Methods:
- Mining underexplored microbial niches for natural products.
- Designing screening methods to avoid rediscovering known scaffolds.
- Repurposing existing libraries of synthetic molecules for antibiotic discovery.
Main Results:
- Identification of promising approaches for novel antibiotic scaffold discovery.
- Potential for new antibiotics to combat multidrug-resistant pathogens.
- Diversification of strategies beyond traditional synthetic tailoring.
Conclusions:
- Discovering new molecular scaffolds is a priority to combat antibiotic resistance.
- Novel approaches like exploring microbial niches and repurposing synthetic libraries show promise.
- Urgent development of new antibiotics is critical for public health.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Antibiotic Selection
Microbiota Modulation by Antibiotics
Development of Antibiotic Resistance
Combined Effects of Drugs: Synergism
Such synergistic combinations...

